Faeth Therapeutics is a clinical-stage oncology company focused on the development of PIKTOR, a multi-node PI3K/AKT/mTOR inhibitor program, advancing toward key milestones. With a founding team that includes the discoverer of the PI3K pathway, we leverage a strong scientific foundation to target significant oncology challenges.
No jobs found. Subscribe below to get notified when we find something for you.
Searching